BD-500 Commercial Deployment
Airborne Pathogen Detection (e.g., COVID-19)
CommercialActive
Key Facts
Indication
Airborne Pathogen Detection (e.g., COVID-19)
Phase
Commercial
Status
Active
Company
About Ave Maria Biotech
Ave Maria Biotech is a private, pre-revenue diagnostics company developing the BD-500, a real-time airborne virus detector. Conceived in response to the COVID-19 pandemic, the device aims to provide immediate, actionable data on airborne pathogens to enable targeted interventions in settings like military bases, hospitals, and cruise ships. The company's strategy involves leveraging government partnerships, such as a CRADA with the U.S. military, and targeting large institutional markets to address the global demand for pandemic preparedness infrastructure.
View full company profile